The diagnosis of disseminated intravascular coagulation

被引:68
作者
Levi, M
de Jonge, E
Meijers, J
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med & Internal Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands
关键词
disseminated intravascular coagulation; fibrin; fibrinogen; thrombin; fibrinolysis;
D O I
10.1016/S0268-960X(02)00032-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Disseminated intravascular coagulation (DIC) is a syndrome characterized by systemic intravascular activation of coagulation, leading to widespread deposition of fibrin in the circulation. In recent years, the pathogenetic pathways leading to DIC have been largely identified, which could result in more precise diagnostic tests for this disorder. However, the clinical and laboratory diagnosis of DIC may remain difficult, since routinely available tests do not specifically assess ongoing thrombin generation. Molecular markers for activation of coagulation and fibrinogen to fibrin conversion are highly sensitive but also disappointedly aspecific for the diagnosis of DIC. Moreover, these tests are often not available in most settings for daily clinical care. A combination of widely available tests, however, may be helpful in making the diagnosis of DIC, according to a recently developed algorithm. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:217 / 223
页数:7
相关论文
共 65 条
  • [1] AKCA S, IN PRESS CRIT CARE M
  • [2] ACQUIRED ALPHA-2-ANTIPLASMIN DEFICIENCY IN ACUTE PROMYELOCYTIC LEUKEMIA
    AVVISATI, G
    TENCATE, JW
    STURK, A
    LAMPING, R
    PETTI, MC
    MANDELLI, F
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1988, 70 (01) : 43 - 48
  • [3] BAUER KA, 1989, BLOOD, V74, P2007
  • [4] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [5] Disseminated intravascular coagulation: Objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response
    Bick, RL
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1996, 22 (01) : 69 - 88
  • [6] BIEMOND BJ, 1995, THROMB HAEMOSTASIS, V73, P223
  • [7] PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 RELEASE DURING EXPERIMENTAL ENDOTOXEMIA IN CHIMPANZEES - EFFECT OF INTERVENTIONS IN THE CYTOKINE AND COAGULATION CASCADES
    BIEMOND, BJ
    LEVI, M
    TENCATE, H
    VANDERPOLL, T
    BULLER, HR
    HACK, CE
    TENCATE, JW
    [J]. CLINICAL SCIENCE, 1995, 88 (05) : 587 - 594
  • [8] ASSESSMENT OF HYPERCOAGULABLE STATES BY MEASUREMENT OF ACTIVATION FRAGMENTS AND PEPTIDES
    BOISCLAIR, MD
    IRELAND, H
    LANE, DA
    [J]. BLOOD REVIEWS, 1990, 4 (01) : 25 - 40
  • [9] Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjects
    Braat, EAM
    Levi, M
    Bos, R
    Haverkate, F
    Lassen, MR
    de Maat, MPM
    Rijken, DC
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 134 (02): : 161 - 167
  • [10] SOLUBLE FIBRIN - A PREDICTOR FOR THE DEVELOPMENT AND OUTCOME OF MULTIPLE ORGAN FAILURE
    BREDBACKA, S
    BLOMBACK, M
    WIMAN, B
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1994, 46 (04) : 289 - 294